Tag: WSC 2025
CATALYST-TNK interim analysis indicates non-inferiority of tenecteplase versus alteplase in ischaemic...
Tenecteplase appears to be a safe and effective alternative to alteplase in the treatment of acute ischaemic stroke within 4.5 hours of symptom onset,...
Siemens Healthineers features advanced mobile stroke unit at WSC 2025
At the 17th World Stroke Congress (WSC; 22–24 October 2025, Barcelona, Spain), Siemens Healthineers showcased its advanced mobile stroke unit (MSU), which has been...
Contact aspiration’s first-pass benefits seemingly “offset” by inferior final recanalisation versus...
In patients with vertebrobasilar artery occlusion (VBAO) stroke undergoing mechanical thrombectomy, first-line contact aspiration appears to produce a greater first-pass effect (FPE) compared to...
Canadian RCT joins growing list of studies demonstrating benefits with MMA embolisation...
The findings of EMMA-CAN—the first randomised controlled trial (RCT) in Canada assessing embolisation of the middle meningeal artery (EMMA) as an adjunct to surgical...
ATLAS meta-analysis consolidates EVT’s efficacy in large-core stroke with benefits seen...
The efficacy and overall safety profile of endovascular therapy (EVT) in large-core ischaemic stroke patients has been reaffirmed by the findings of ATLAS—a systematic...
